Abstract P1-16-02: Phase II study of the feasibility and safety of radium-223 dichloride in combination with hormonal therapy and denosumab for the treatment of patients with hormone receptor-positive breast cancer with bone-dominant metastasis
Year: 2018
Type: conference-abstract
Source: Cancer Research
Authors: RK Tahara, T Fujii, B Saigal, NK Ibrahim, S Damodaran, CH Barcenas, JL Murray, BA Chasen, Y Shen, DD Liu, GN Hortobagyi, D Tripathy, NT Ueno
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Topic: Bone health and treatments
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2790583269